Sanjay J. Mathew, MD
Sanjay J. Mathew, MD, is the Marjorie Bintliff Johnson and Raleigh White Johnson Jr. vice chair for research and a professor in the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine. He is also an active clinician. His research program focuses on experimental therapeutics and pathophysiology related to treatment-resistant mood and anxiety disorders and PTSD, with a particular focus on rapid-acting and novel pharmacotherapies.
Dr. Mathew graduated from Dartmouth College and Baylor College of Medicine. He then trained in psychiatry and mood/anxiety disorders research at Columbia University and the New York State Psychiatric Institute. Prior to his current position at Baylor College of Medicine, he served as faculty at the Icahn School of Medicine at Mount Sinai, where he co-directed the Mood & Anxiety Disorders Program. Dr. Mathew has authored and co-authored over 180 manuscripts and book chapters, serving on the editorial board of several journals. In 2016, he co-edited the book, Ketamine for Treatment-Resistant Depression. He’s on the boards of the American Society of Clinical Psychopharmacology and the Anxiety and Depression Association of America, where he serves as the chief medical officer. He is also an elected fellow of the American College of Neuropsychopharmacology.